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Has the short-term effect of black smoke
exposure on pneumonia mortality been
underestimated because hospitalisation is
ignored: findings from a case-crossover study
Matthew Gittins1*, Roseanne McNamee1, Melanie Carder2, Iain Beverland3 and Raymond M Agius2
Abstract
Background: Short-term associations have been demonstrated between air pollution and respiratory mortality
including pneumonia. Studies typically estimate exposure based only on place of residence, yet many are in
hospital prior to death. This study investigates lag length and tests the hypothesis that the effect of ‘black smoke’ is
greater when restricted to pneumonia deaths in the community – Community Deaths from Pneumonia.
Methods: A time-stratified case-crossover design using conditional logistic regression estimated the daily percentage
increase in risk of pneumonia mortality in relation to ‘black smoke’ in the preceding 30 days. Cases were pneumonia
deaths in Edinburgh 1981–1996. Multiple ‘control’ periods, were defined using the same weekdays for the same month
as the case death. Lag structure was investigated by a stratified lag model with five 6-day periods and by distributed
lag models. Hospital admissions data, defined a community death as someone who had not been in hospital in
any of the 30 days before death.
Results: Of 14,346 subjects who died from pneumonia, 7,536 were community deaths. Larger estimated increases
in risks were seen in the community for all lag periods. Both stratified and distributed lag methods suggested
positive effect estimates for 18 days after exposure and negative thereafter; the average percent increase per day
across the 18 days was 0.70% (95% C.I. 0.29-1.14) for community subjects and 0.30% (95% C.I. 0.03-0.59) for all
subjects.
Conclusions: Studies which fail to account for hospitalisation may underestimate exposure effects as stronger
pollution effects on mortality were evident in community based subjects.
Keywords: Air pollution, Time-stratified, Case-crossover, Community, Lag stratified, Lag distributed
Background
Many studies worldwide have demonstrated an associ-
ation between air pollution and all cause mortality [1,2],
specifically respiratory mortality [3-5]. In 2011, pneu-
monia was the 6th leading cause of death in England and
Wales for males (10,824) and 4th (14,872) for females [6].
However, only a few studies - with limited findings - have
specifically investigated associations between pneumonia
related deaths and ambient air pollution. Schwartz and
Dockery, indicated an increase in pneumonia mortality of
11% (95% C.I. −3%, 27%) per 100 μgm-3 increase of Total
Suspended Particles (TSP) [7]. Halonen et al. demon-
strated a percentage increase in pneumonia mortality in
Finland of 3.16% (95% C.I. −2.64%, 9.32%) per increase in
inter-quartile range of a 5 day Coarse Particle Matter
(PM10-2.5) mean [8]. Zanobetti et al. proposed that air
pollution may be a predisposing factor to Community
Acquired Pneumonia (CAP) and that subjects with CAP
rather than Hospital Acquired Pneumonia, may be more
susceptible to the effects of air pollution [9]. Studies
such as Neupane et al. have indicated a relationship be-
tween long-term exposure to air pollution and emergency
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visits to hospital with Community Acquired Pneumonia
[10]. However, so far no study has investigated the effect
of pollution on deaths from Community Acquired
Pneumonia only.
Much of the evidence for the association between air
pollution and general mortality has focused on exposure
in a short time period – less than 40 days prior to death
[2,11]. This focus on short to medium exposure may be
appropriate for pneumonia which is generally an acute
condition, though often associated with chronic under-
lying lung disease. Frequently, a deceased individual’s
exposure is inferred from information regarding their
place of residence with little or no attempt to take account
of subject’s actual location, circumstances or activities. Ex-
posure is typically assumed to be the same for all subjects
living within a given distance from a single pollution
monitor or an average of multiple monitors within the
area [1,11]. More recent studies, trying to improve expos-
ure estimates, have taken into account traffic density and
other geographical information regarding the subjects
neighbourhood or city [12,13]. The presumption still
remained that the deceased was in the geographical loca-
tion of residence during the exposure period; in fact it is
common for people to die in non-residential locations
(65.3% in a NHS hospital/Hospice in England and Wales
[14]). If the hospital is located close to the place of
residence, one might reasonably suppose that a patients’
exposure to outdoor pollution might be reduced when
confined indoors [15]. Epidemiological observations
have shown that deaths associated with air pollution,
specifically TSP and Particle Matter with a diameter less
than 10 μm (PM10), are disproportionately increased
outside of hospital [16,17]. In addition, Jansen et al.
2002, found that the health effects of PM10 on cardio-
vascular disease and COPD in 14 U.S. cities decreased
significantly as the proportion of homes with air condi-
tioning increased [18]. Previous attempts at comparing
risks in and out of hospital, such as Téllez-Rojo et al.
2001 and Zeka et al. 2006, have shown significant in-
creased risk of death from respiratory or cardiovascular
causes, in some cases up to a threefold increase. These
studies have primarily used location at time of death
without confirming location during exposure [19,20].
Failure to take account of hospitalisation during exposure
could lead to further effect underestimation if a substantial
fraction of the population experience reduced exposure in
air-conditioned hospitals. A large proportion of subjects
hospitalised during exposure might explain why some
observational epidemiology studies based on routinely
collected data may struggle to replicate previously dem-
onstrated associations between pollution and pneumo-
nia caused mortality [21].
Pneumonia occurs usually as a result of bacterial or
viral infection. Often progressing rapidly within 24 hours,
it presents symptoms such as coughing, chest pain,
shortness of breath, and fever. Pneumonia can generally
be diagnosed reliably through medical consultation and
a chest radiography [22]. The relatively quick onset of
the disease, short diagnosis period, and the time varying
nature of air pollution exposure satisfies the conditions
for employing the case-crossover design [23]. This design
offers protection against possible subject level confounders
without the need for complex modelling of mortality levels
over time.
This study investigated the effect of ‘black smoke’
(BS) over 30 days prior to pneumonia mortality using a
time-stratified case-crossover design [24]. We tested the
primary hypothesis that estimated association would be
greater in subjects who spent the exposure period in the
‘community’ (i.e. not in hospital) compared to those who
spent some or all of the period in hospital. Members of
the former group will be defined as subjects with a Com-
munity Death from Pneumonia (CDPs) which should be
distinguished from CAP; CAP refers to a clinical category
based on the source of pneumonia, CDP are a subgroup
of CAP. Concurrently, hypothesis generating analyses ex-
plored how exposure affects mortality from pneumonia
across the lag period. Subsequently, analyses based on
the lag periods which showed effects on mortality were
repeated for subgroups defined by gender and age. It is
conceivable that differences in lifestyle between these
groups could influence exposure or that there is in-
creased susceptibility in older age, leading to differential
observed effects of BS on CDPs.
Methods
Deaths due to pneumonia (ICD-9 codes 480–487 pre
2000) between January 1981 and December 1996 from
Edinburgh, Scotland formed the cases. Separately, infor-
mation was provided on all admissions to hospital caused
by respiratory, cardiovascular, lung cancer, diabetes, and
digestive related causes for the same time period and loca-
tion. The Information Services Division of NHS National
Services in Scotland provided both datasets, they included;
date of death, age, gender, admission dates, primary and
secondary cause of admission and death, and if the patient
died in hospital. The two files – one of deaths and one of
hospital admissions – were linked to determine if the sub-
ject had been in hospital during the 30 days prior to death.
Community Acquired Pneumonia refers to those subjects
who did not acquire pneumonia from a hospital. Subjects
with CAP may subsequently enter and later die in hospital.
These subjects will not be included in our data as they will
have had at least one day in hospital altering their expos-
ure and increasing their chances of a secondary Hospital
Acquired Pneumonia infection. A death was considered to
be a Community Death from Pneumonia if the hospital
admission data showed that the subject had not been in
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hospital for any of the 30 days prior to death. A CDP
subject is therefore a special subgroup of the CAP deaths.
Daily black smoke air pollution data was obtained from
one centrally located background monitoring site and
hourly ambient air temperature (between 7 am-11 pm)
was provided by the Scottish Meteorological Office. This
was used to give daytime mean temperature and mean
pollution levels for the area. For each date of death, or
case day, ‘black smoke’ daily results for the month prior
were averaged firstly across 1–30 days and then separately
for 1–6, 7–12, 13–18, 19–24, and 25–30 days. These
formed the exposure variables for the cases. Same day
exposure (lag 0) was not included as pneumonia has a
minimum 24 hr incubation period [22], and same day
exposure potentially includes exposure after death.
Temperature displays temporal associations with pollution
levels, and has previously been shown in this population
to have an approximately double linear relationship with
mortality, with a knot at 11°C [25]. Hence, two continuous
temperature variables were calculated as, “high” (t-11 if
≥11°C, 0 otherwise) and “low” (t-11 if ≤11°C, 0 otherwise),
where t is the daytime mean temperature. Average
temperature across lags 1–30 days for both “low” and
“high” variables was included in all models. Including pol-
lution and temperature exposure lags (up to 30 days prior)
reduces the chances of underestimating the exposure ef-
fect [11]. Further information regarding the data source
and variable manipulations can be found elsewhere [25].
The 30 days prior to the date of death from pneumonia
defined the case exposure period. In case-crossover de-
signs, reduced bias allows for a time-stratified design to
select matched control periods [26]. Control days were
defined as all equivalent days of the week within the
same month as the case day, in order to account for any
weather, seasonal, or day of the week confounding [27].
For example, if the event occurred on the second Mon-
day of May then the control days became all other Mon-
days of May. The control exposure period was then
30 days prior to the control day, and temperature and
pollution variables were formed from these periods.
Ethical approval for the study was granted by the NHS
Research Ethics Committee (Ref – 11/NW/0768) and
the Privacy Advisory Committee associated with the In-
formation Services Division Scotland once appropriate
measures had been implemented to ensure any partici-
pant information was securely stored.
Statistical analysis
Conditional logistic regression [28], initially compared
average exposure between the case and controls over
30 days prior to death (Model 1). To investigate expos-
ure during the 30 days, a lag-stratified model fitted five
exposure variables each representing a 6 day lag period
(Model 2). To avoid problems comparing estimates
based on different period lengths (e.g. 30 days and
6 days) [25,29], all estimated coefficient were divided by
the number of days on which the mean was based. Hence,
BS results are expressed as percentage increase in risk as-
sociated with an increase of 10 μgm-3 ((eB*10-1)*100, where
B =model coefficient) on any individual day within the lag
period. Similarly, both continuous temperature variables
are also expressed as a percentage increase in risk corre-
sponding to a decrease in 1°C of temperature for any indi-
vidual day during lag period ((e-B-1)*100). The association
between BS and All Pneumonia deaths (AP) was estimated
before restricting to the subgroup (CDP) deemed to have
the greatest potential exposure. To test if a significant
difference in exposure effects occurred, an interaction
term was included to compare CDP and non-CDP for
each BS lag term, and the Log-likelihood-ratio was used
to test the difference.
Within each lag period the average daily value across
the lag period was calculated so long as a minimum of
four out of every six days contained a pollution estimate.
The analysis was then performed with any subject with
complete data for the case day and at least one control
day. This resulted in 4.5% and 4.3% (AP and CDP, re-
spectively) of subjects dropped due to either missing
pollution data in the case day or all control days.
The effect of a change in exposure on an individual day
might be expected to vary across subsequent days and
eventually fall to zero [30]. An estimated effect might even
become negative afterwards if the ‘high risk’ pool of sub-
jects is depleted without sufficient replenishment, causing
a mortality rate lower than the underlying rate [17]. In
addition to lag-stratified, a quadratic distributed lag [30]
estimated the lag time, L, before which the estimated ef-
fects are positive. For simplicity in further analysis, average
exposure across the period (0,L) days was modelled for
each gender and two age groups (≤80 and >80). Analysis
was performed using STATA version 11 [31].
Results
A total of 15,784 people had pneumonia as primary or
secondary cause of death in Edinburgh between 1981
and 1996. However, missing pollution data (9.8% of days
during the time period) for either a subject’s case day or
all of the subject’s control days meant only 14,346 cases
with 47,431 control days were eligible for the analysis.
Table 1 gives descriptive statistics for the daily average
BS air pollution, air temperature and demographic char-
acteristics for both all pneumonia (AP) and CDP (52.5%
of the AP) subject groups. Further, summary statistics
indicated an inter-quartile range approximately 10 μgm-3
for each lag period.
The percentage change in relative risk (%RR), with 95%
confidence intervals, are given in Table 2 for an increase
in BS of 10 μgm-3 or a temperature decrease of 1°C on any
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individual day. MODEL 1 and 2 refers to the model with
BS and temperature averaged over 1–30 days and BS
split into five smaller lag periods, respectively. Correl-
ation coefficients indicate strong correlation between
average exposures in adjacent lag periods (≈0.7) however
the corresponding variance inflation factors (VIF = 2.01 to
2.78) did not indicate the presence of collinearity between
the five lag periods in model 2 [32]. To easily compare
effect sizes between lag periods the percentage change in
relative risk corresponds to the effect of a change in BS or
temperature on any individual day within the associated
lag period. The differences in %RR between AP and CDP
along with corresponding significance levels are also
given.
MODEL 1 considers the effects of exposure on each of
the 30 days to be equal. An increase of 10 μgm-3 black
Table 1 Descriptive statistics of exposure data and study subjects split by all pneumonia and community deaths from
pneumonia
Mean S.D. Median IQR Min Max
Daily Ave Air Temp (°C) 9.4 5.1 9.4 8 −12.7 24.48
Daily Ave BS (μgm-3) 12.7 13.3 9 10 1 194
Lag 1–6 days Ave BS (μgm-3) 12.9 10.8 9.3 9.5 1 95.2
Lag 7–12 days Ave BS (μgm-3) 13 11.1 9.5 9.6 1 95.2
Lag 13–18 days Ave BS (μgm-3) 13.1 11.3 9.5 9.7 1 95.2
Lag 19–24 days Ave BS (μgm-3) 13.1 11.2 9.5 9.5 1 95.2
Lag 25–30 days Ave BS (μgm-3) 13 11.2 9.5 9.3 1 95.2
Lag 1–30 days Ave BS (μgm-3) 13.2 9.2 10.1 9.3 2.7 73.2
Age (CDP) 79.13 12.6 82 12 0 108
Age (Non-CDP) 79.21 11.92 81 13 0 108
Age (AP) 79.15 12.2 81 13 0 108
Gender Age Grouped
Categories Male Female <80 ≥80 Total
CDP only Subjects (%) 3,409 (45.2) 4,127 (54.8) 3,064 (40.7) 4,472 (59.3) 7,536 (100)
Non-CDP only Subjects (%) 3,166 (48.2) 3,644 (46.9) 3,109 (50.4) 3,701 (45.3) 6,810 (47.5)
All Pneumonia Subjects (%) 6,575 (45.8) 7,771 (54.2) 6,173 (43.0) 8,173 (57.0) 14,346 (100)
BS = Black Smoke.
Table 2 Percent change in risk for lagged black smoke air pollution and pneumonia mortality: repeated for AP
(All pneumonia), CDP (Community death from pneumonia) & Non-CDP
AP CDP only Non - CDP only
Lag (days)
% RR
change
95% C.I.
% RR
change
95% C.I.
% RR
change
95% C.I.
|CDP|-|AP|
diff
|CDP-Non
CDP| diff
P-val
MODEL 1 Black
Smoke
1-30 0.08% −0.17%, 0.35% 0.19% −0.16%, 0.58% 0.01% −0.34%, 0.40% 0.11% 0.18% 0.285
Air Temp “Low” 1-30 0.20% 0.11%, 0.29% 0.22% 0.09%, 0.35% 0.16% 0.03%, 0.30% 0.02% 0.06% 0.502
Air Temp “High” 1-30 −0.05% −0.20%, 0.10% −0.20% −0.40%, 0.00% 0.11% −0.11%, 0.34% 0.15% 0.31% 0.059
MODEL 2 Black
Smoke
1-6 0.12% −0.37%, 0.62% 0.56% −0.14%, 1.29% −0.31% −0.99%, 0.41% 0.44% 0.87% 0.022
7-12 0.05% −0.42%, 0.53% 0.32% −0.33%, 1.00% −0.25% −0.92%, 0.45% 0.28% 0.57% 0.023
13-18 0.40% −0.08%, 0.90% 0.71% 0.03%, 1.42% 0.14% −0.56%, 0.86% 0.31% 0.57% 0.163
19-24 −0.09% −0.55%, 0.38% −0.16% −0.79%, 0.50% 0.05% −0.63%, 0.75% 0.06% 0.21% 0.272
25-30 −0.11% −0.57%, 0.36% −0.39% −1.01%, 0.25% 0.34% −0.35%, 1.06% 0.28% 0.73% 0.008
Air Temp “Low” 1-30 0.19% 0.10%, 0.29% 0.19% 0.06%, 0.32% 0.18% 0.05%, 0.32% 0.00% 0.01% 0.487
Air Temp “High” 1-30 −0.05% −0.19%, 0.10% −0.20% −0.39%, 0.01% 0.09% −0.12%, 0.33% 0.15% 0.29% 0.058
%RR Change - percentage change in Relative Risk, associated with an increase of 10 μgm-3 BS or a decrease of 1°C, on any individual day within the lag period,
with corresponding 95% Confidence Interval (95% C.I.).
Model 1 - One 30 day lag, Model 2 - The 30 days split into 5 lags of 6 days each fitted simultaneously.
CDP – AP Diff - The difference in the magnitude of the effect size between AP and CDP (CDP-AP).
CDP-Non CDP Diff - The difference in the effect size between CDP and Non-CDP (CDP – Non CDP).
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smoke on any of the 30 days, showed a small rise in AP
relative risk increasing to 0.19% in the CDP group,
resulting from a %RR difference of −0.18% between CDP
and non-CDP subjects (CDP-non-CDP %RR). When the
30 days is split into 5 lag periods (MODEL 2), the mag-
nitude of the effect is always larger in the CDP subjects,
of whom the largest changes in %RR are seen in the 1–
6, 7–12, and 13–18 day lags. This 18 day period prior to
death appeared to be the high risk period, as an increase
%RR is observed in 1–6, 7–12, and 13–18 day lags
whereas a decrease is observed in the 19–24 and 25–
30 day lags. Figure 1 plots the change in log rate ratio
associated with the 30 day lag period for both AP and
CDP as modelled using the quadratic lag distribution
model. As suggested in Table 2, the CDP group showed
larger effects with a more rapid decline crossing zero at
approximately 21 days, almost 2 days earlier than the
more gradual AP decline in risk.
Low Temperature effects changed very little, a 1°C
decrease corresponded to an increase in relative risk
approximately the same for both AP and CDP. In com-
parison, a 1°C decrease in high temperature shows a small
decrease in risk in AP that increases in magnitude in the
CDP group.
A secondary analysis concentrated on the minimum
lag period where increased risk was observed (18 days)
and split the data into the subgroups; gender (male/
female), and age (<80/≥80). In all but low temperature for
males & age < 80 an increase in %RR was seen in the CDP
group. The CDP subjects indicated a stronger %RR in
males (0.83% - 95% C.I. 0.21%, 1.51%) compared to fe-
males (0.61% - 95% C.I. 0.08%, 1.19%). Subjects aged 80 or
above showed larger relative risk in AP (0.37% - 95% C.I.
0.00%, 0.77%; to 0.23% - 95% C.I. -0.17%, 0.66% in <80) but
the difference disappeared when restricted to CDP sub-
jects (0.71% - 95% C.I. 0.18%, 1.30% and 0.71% - 95% C.I.
0.10%, 1.38%, respectively). Analysis was repeated for
subjects aged less than 65 to investigate different age dis-
tributions of pneumonia subtypes. Even though the effect
sizes showed slightly larger differences in magnitude com-
pared to the less than 80 group they were highly imprecise
due to substantially smaller sample size, hence they have
not been reported here. Comparisons using the log-
likelihood test were performed between the gender and
age groups; in all cases the difference was non-significant
at the 5% level. Further information can be found in the
Additional file 1: Table S1.
Discussion
These findings suggest that a subject’s location is an
important consideration when assessing the effect of
ambient air pollution on pneumonia mortality. In this
study, the percentage relative risk of air pollution was
significantly higher in CDP compared to AP by 0.44%
(1–6 day lag), 0.28% (7–12 day lag) with a further
important but non-significant increase of 0.31% in the
13–18 day lag. The 18 days prior to death indicated a
lag period of increased risk, with the largest relative
risk (CDP = 0.71% (0.03%, 1.42%)) in the 13–18 day lag
period. Prior to the 18th day a decrease in relative risk oc-
curred, with the magnitude increasing in the lag period
furthest from the event. The quadratic distributed lag plot
confirmed an increased risk period of 20–22 days prior to
the event. The decrease effect on mortality may be due to
a small pool of people susceptible to dying from pollution
effects [17]. Initial changes in pollution cause the pool to
diminish more rapidly than it can be replenished, creating
a net deficit in the number of susceptible subjects; this
leaves a larger proportion of stronger subjects to experi-
ence the longer lag periods and hence, a reduction in
deaths.
In all lag periods, irrespective of the direction, the
magnitude of the effect is greater in the CDP group.
Hence, significant associations between BS and pneumo-
nia mortality may have been overlooked in previous
studies that have not taken into account location during
exposure. Removing those who may have had a misleading
exposure (due to hospitalisation) may have given a larger
observed effect. Increased risk may be experienced in
community based subjects due to reduced accesses to
medical care that may have been able to prevent early
symptoms from progressing to a critical phase. The bias
associated with earlier recognition, and more timely and
aggressive therapeutic intervention may be the reason for
the apparently negative %RR associated with an increase in
BS of 10 μgm-3 within the “non-CDP” only subject group.
This study finds a similar increase in BS exposure
effects when compared to U.S. studies of TSP/PM10 on
all cause mortality when restricted to deaths located
outside of hospital [16,17]. Black smoke contains finer
particle fractions dominated by combustion emissions
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Figure 1 The quadratic lag distribution model for subjects with
all pneumonia and community deaths from pneumonia.
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which are more closely associated with health outcomes
than PM10 or PM2.5, and so BS filter darkness measure-
ments are a better marker for harmful combustion-related
particles [33]. Currently, few published articles comparing
indoor and outdoor BS levels exist. Gotschi et al. com-
pared indoor and outdoor BS and PM2.5 for 186 homes
in Athens, Basel, Helsinki and Prague. The median
indoor-outdoor ratios of BS were slightly less than
PM2.5, however, Spearman correlation coefficients were
larger, possibly due to stronger indoor influences on
PM2.5 [34]. Hoek et al. gave filter darkness regressions
slopes (0.63-0.84) between indoor-outdoor concentra-
tions in homes of four European cities [35]. Limited
information with inconsistent outcomes, often due to
small sample sizes (N ≤ 50), is available comparing in-
door and outdoor personal particulate matter exposure
[36-38]. Janssen N.A.H et al. investigated personal, in-
door and outdoor fixed site exposure to PM10 in 37 par-
ticipants from Amsterdam and PM2.5 and BS in 36 and
46 participants from Amsterdam and Helsinki respect-
ively. Sampling was taken for 24 hr periods, bi-weekly,
over six months. In both cases, median concentrations
were found in the personal monitors, followed by out-
door monitoring and then indoor. High correlations
were produced between personal and outdoor fixed site
monitors indicating that fixed site monitors are a good
representation of the day-to-day variation in particulate
matter exposure [39,40]. However, high correlation does
not imply the same absolute levels. The underlying
premise; that exposure to airborne pollutants is reduced
in hospitalised subjects; is supported by Wang et al.
which showed a reduction in indoor concentrations of
PM10 and PM2.5 in 2 of 4 hospitals in Guangzhou, China
[41]. Subsequently, Wang et al. and later Morawska
et al. further determined that a mechanical ventilation
air conditioning system produced the lowest indoor-
outdoor PM10 ratios [42,43]. Indoor air quality is an im-
portant issue for hospitals. However, currently the quantity
of literature available on the relationship between indoor
and outdoor air pollution, particularly regarding hospitals,
is limited. Further observational studies are required to
supplement understanding of the reduction and fluctua-
tions in indoor hospital air pollution concentrations, in
terms of distance from combustion sources, changes in
ventilation systems and meteorological conditions [44].
One possible alternative explanation for the increase
in relative risk occurring within the CDP group is that
exposure may have a differing interaction with certain
types of pneumonia that are specifically associated with
the community. Pneumonia infection can be caused by a
variety of micro-organisms. Hospital Acquired Pneumonia
is primarily caused by Staphylococcus aureus or Gram-
negative enterobacteria, and CAP is most commonly
Streptococcus pneumoniae (35% of CAP cases) [45].
Streptococcus pneumonia has an incubation period of 1–
3 days, shorter than other pathogens such as Haemophilus
influenzae and Mycoplasma pneumonia with incubation
periods of 2–4, and 6–32 days respectively [22]. Variation
in source and incubation period may be a contributing
confounding factor to the difference in BS effect on CDP
mortality. Limited information from ICD coding con-
structed from the death certificate, allowed the pneumonia
deaths to be classified into; bronchopneumonia (81%),
pneumococcal & streptococcal pneumonia (5%), organism
unspecified (13%), and all others (1%), of which 67%,
52%, 47%, and 35%, respectively were CDP subjects.
Change in exposure effects on differing underlying
causes of pneumonia may be a possible explanation for
higher relative risk in CDP deaths. If type of pneumonia
was the only explanation for higher RR, then we might
expect the RRs for BS within the categories of pneumonia
to be the same. In fact, the same pattern of a higher RR
for CDP compared to hospital deaths was found for; bron-
chopneumonia, and pneumococcal & streptococcal types
(although not for; organism unspecified and all other types
which had much smaller sample sizes reducing the power
available to determine the true effect).
However, pollution itself may be the causal factor.
Particulate pollution may increase the risk of contracting
pneumonia in a number of ways; by impairing microbial
clearance via the mucociliary mechanism [46], hindering
macrophage phagocytosis [47], or causing intense capillary
engorgement and loss of epithelium [48]. These effects
might require an indeterminate dose (product of exposure
concentration, respiratory minute volume and time) to
materialise before manifesting in an increased susceptibil-
ity to pneumonia mortality. The temporal relationship
between air pollution and pneumonia death analysed
here may therefore comprise a period of chemical insult
before, as well as a diagnosis to death interval envelop-
ing the ‘incubation period’ as classically defined. These
varying and relatively indeterminate periods may thus
explain why %RR is reduced in the 7–12 day lag com-
pared to 1–6 and 13–18 day lags (Table 2).
A comparison of the BS lag periods within the two
models indicated the possible presence of mortality dis-
placement within the data. Mortality displacement, also
known as harvesting, is the accelerated progression of a
frail sub-population to death followed by a delay in its
replenishment. This is thought to be illustrated by an
increase in the death rate from its baseline for a certain
period after exposure, followed by a period when the
death rate seems to be below expected [17]. In Table 2
the lags post 18 days seems to suggest a negative relative
risk but in fact this may be due to the shrinking of the
at risk population. When the overall effect across the
30 days is estimated (Table 1), the positive and negative
estimates balance out to some extent. These results are
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therefore consistent with the mortality displacement
phenomenon. Pneumonia mortality may be more sus-
ceptible to ‘harvesting’ as pneumonia is prevalent in the
elderly [9,49] and is often the final cause in the chain of
causes leading to death, implying a high incidence in
the frail sub-population compared to the general popu-
lation. If mortality displacement is present then it would
have been easy to miss any risk period if the model only
included one term representing average black smoke
across 30 days.
The stronger risk experienced for the 18 days prior to
death in males within the CDP group may be due to a
more outdoors lifestyle in males causing an increased
interaction with exposure. Younger subjects may also be
expected to experience higher exposure to outdoor pollu-
tion concentrations. Yet we found no age group difference
in risk within the CDP group possibly due to relatively few
subjects aged 65 or less (9.2%), or due to elderly patients
being allowed to die at home rather than in hospital. One
could further argue that it is difficult to accurately deter-
mine the exposure level for these subjects as the area con-
tains only one exposure measurement site. Any exposure
misclassification could be reduced if the number of
measurement sites could be increased, making it easier
to evaluate local variations in pollution levels. Even then,
it is difficult to determine a subject location during the
entire exposure period, especially when multiple control
exposure periods are used. Other than to explore the re-
lationship between BS and mortality; restricting the data
to an 18 day lag period was not a part of our original
aims and so we do recognise that we lose some validity
in our p-values. However, as the 18 day lag period
showed significant increases in risk we felt it was worth
investigating further.
The study time period (1981–1996) does not necessarily
limit these results to a historical interest only given that
the primary aim was to compare the effect of pollution on
subjects in the community versus within hospital. In fact,
the higher outdoor concentrations of black smoke in the
1980's and early 1990's were advantageous for testing this
hypothesis given that higher pollution concentrations
meant that the incidence of pollution related pneumonia
mortality would have been higher and this would make
the difference in risk, if any, associated with indoor and
outdoor exposure easier to detect. The dominant source
of black smoke during both the study period and present
day were from road vehicles as most smoke control proce-
dures to reduce combustion of coal for domestic heating
and industrial energy would already have been imple-
mented by the start of the study period. However, the
chemical composition of fine black particles may have
altered somewhat since the study period as a result of
technological changes in vehicle engine and emissions
control systems. It is not possible to directly characterise
the extent of such changes as it is not possible to select-
ively collect black particles from non-black particles
during atmospheric sampling for chemical analyses.
Conclusions
In conclusion, evidence suggests that a subject’s location
is an important factor in relation to their likelihood of
pneumonia mortality due to particulate pollution expos-
ure. Including subjects who may have a lower exposure
may increase bias in your results and as shown here
underestimate the true effect of exposure on pneumonia
deaths. The risk to mortality in all subjects, and in particu-
lar within the CDP group, tends to last a minimum of
18 days and peaks at the 13–18 day lag. This confirms that
air pollution effects do exist beyond short term exposure
periods such as 1–3 days, making it is important to inves-
tigate extended exposure periods of at least two to three
weeks prior to death.
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